|
1
|
Burnier MN, McLean IW, Zimmerman LE and
Rosenberg SH: Retinoblastoma. The relationship of proliferating
cells to blood vessels. Invest Ophthalmol Vis Sci. 31:2037–2040.
1990.PubMed/NCBI
|
|
2
|
Rössler J, Dietrich T, Pavlakovic H, et
al: Higher vessel densities in retinoblastoma with local invasive
growth and metastasis. Am J Pathol. 164:391–394. 2004.PubMed/NCBI
|
|
3
|
Jockovich ME, Murray TG, Escalona-Benz E,
Hernandez E and Feuer W: Anecortave acetate as single and adjuvant
therapy in the treatment of retinal tumors of
LHBETATAG mice. Invest Ophthalmol Vis Sci.
47:1264–1268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee SY, Kim DK, Cho JH, Koh JY and Yoon
YH: Inhibitory effect of bevacizumab on the angiogenesis and growth
of retinoblastoma. Arch Ophthalmol. 126:953–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang H, Cheng R, Liu G, et al: PEDF
inhibits growth of retinoblastoma by anti-angiogenic activity.
Cancer Sci. 100:2419–2425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pezzolo A, Parodi F, Corrias MV, Cinti R,
Gambini C and Pistoia V: Tumor origin of endothelial cells in human
neuroblastoma. J Clin Oncol. 25:376–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ricci-Vitiani L, Pallini R, Biffoni M, et
al: Tumour vascularization via endothelial differentiation of
glioblastoma stem-like cells. Nature. 468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang R, Chadalavada K, Wilshire J, et al:
Glioblastoma stem-like cells give rise to tumour endothelium.
Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nork TM, Poulsen GL, Millecchia LL, Jantz
RG and Nickells RW: p53 regulates apoptosis in human
retinoblastoma. Arch Ophthalmol. 115:213–219. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schlamp CL, Poulsen GL, Nork TM and
Nickells RW: Nuclear exclusion of wild-type p53 in immortalized
human retinoblastoma cells. J Natl Cancer Inst. 89:1530–1536. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seigel GM, Hackam AS, Ganguly A, Mandell
LM and Gonzalez-Fernandez F: Human embryonic and neuronal stem cell
markers in retinoblastoma. Mol Vis. 13:823–832. 2007.PubMed/NCBI
|
|
12
|
Zhong X, Li Y, Peng F, et al:
Identification of tumorigenic retinal stem-like cells in human
solid retinoblastomas. Int J Cancer. 121:2125–2131. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ and
Kim KW: Establishment and characterization of a novel,
spontaneously immortalized retinoblastoma cell line with adherent
growth. Int J Oncol. 31:585–592. 2007.PubMed/NCBI
|
|
14
|
Reid TW, Albert DM, Rabson AS, et al:
Characteristics of an established cell line of retinoblastoma. J
Natl Cancer Inst. 53:347–360. 1974.PubMed/NCBI
|
|
15
|
Kato MV, Shimizu T, Ishizaki K, et al:
Loss of heterozygosity on chromosome 17 and mutation of the p53
gene in retinoblastoma. Cancer Lett. 106:75–82. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laurie NA, Donovan SL, Shih CS, et al:
Inactivation of the p53 pathway in retinoblastoma. Nature.
444:61–66. 2006.
|
|
17
|
Danovi D, Meulmeester E, Pasini D, et al:
Amplification of Mdmx (or Mdm4) directly contributes
to tumor formation by inhibiting p53 tumor suppressor activity. Mol
Cell Biol. 24:5835–5843. 2004.
|
|
18
|
Lu F, Chi SW, Kim DH, Han KH, Kuntz ID and
Guy RK: Proteomimetic libraries: design, synthesis, and evaluation
of p53-MDM2 interaction inhibitors. J Comb Chem. 8:315–325. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pokroy R, Tendler Y, Pollack A, Zinder O
and Weisinger G: p53 expression in the normal murine eye. Invest
Ophthalmol Vis Sci. 43:1736–1741. 2002.PubMed/NCBI
|
|
20
|
Weisinger G, Tendler Y and Zinder O:
Quantification of p53 expression in the nervous system. Brain Res
Brain Res Protoc. 6:71–79. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Camphausen K, Purow B, Sproull M, et al:
Influence of in vivo growth on human glioma cell line gene
expression: convergent profiles under orthotopic conditions. Proc
Natl Acad Sci USA. 102:8287–8292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura T, Fidler IJ and Coombes KR: Gene
expression profile of metastatic human pancreatic cancer cells
depends on the organ microenvironment. Cancer Res. 67:139–148.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fonsato V, Buttiglieri S, Deregibus MC,
Puntorieri V, Bussolati B and Camussi G: Expression of Pax2 in
human renal tumor-derived endothelial cells sustains apoptosis
resistance and angiogenesis. Am J Pathol. 168:706–713. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Streubel B, Chott A, Huber D, et al:
Lymphoma-specific genetic aberrations in microvascular endothelial
cells in B-cell lymphomas. N Engl J Med. 351:250–259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holash J, Maisonpierre PC, Compton D, et
al: Vessel cooption, regression, and growth in tumors mediated by
angiopoietins and VEGF. Science. 284:1994–1998. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lyden D, Hattori K, Dias S, et al:
Impaired recruitment of bone-marrow-derived endothelial and
hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nat Med. 7:1194–1201. 2001. View Article : Google Scholar : PubMed/NCBI
|
